Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Below Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. SPY
4. IQMX
5. EROC
6. MSTR
7. SEER
8. NVDA
9. RIVN
10. TSLA

Go back to Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Below Guidance

Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights

March 14, 2019 7:01 AM EDT

WARREN, N.J., March 14, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today reported financial results for the fourth quarter and full year ended December 31, 2018 and provided an update on recent developments in its business.

"Aquestive made significant progress in 2018 by... More